| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/05/2007 | CN101028086A Health-care food with liver-protecting function |
| 09/05/2007 | CN101028085A Health-care food with liver-protecting function |
| 09/05/2007 | CN101028084A Health-care food with liver-protecting function |
| 09/05/2007 | CN101028083A Health-care food with liver-protecting function |
| 09/05/2007 | CN101028077A Method for preparing cactus nutrient dried brown rice vermicelli |
| 09/05/2007 | CN101028070A Mangosteen extract, its production and use |
| 09/05/2007 | CN101028060A Quelite with health-care function |
| 09/05/2007 | CN101028058A Bone gourmet powder and its production |
| 09/05/2007 | CN101028053A Preparing and preserving method for Wubao liquid |
| 09/05/2007 | CN101028025A Erythritol sandwiched chocolate |
| 09/05/2007 | CN100335499C C-terminal amino acid lactone modified extrasin alpha-1 and its uses |
| 09/05/2007 | CN100335464C Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 09/05/2007 | CN100335120C Chinese medicine vemedy for treating globus hysteritis and preparing method |
| 09/05/2007 | CN100335075C Method for extracting effective component from sophora alopecuroide for reducing blood fat and its medicinal use |
| 09/05/2007 | CN100335070C Coriolus versicolor zymolyte, its preparation method and use for adjuvant as alcoholic drink |
| 09/05/2007 | CN100335067C Gastropathy treating medicine |
| 09/05/2007 | CN100335062C Use of Ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition contg. same |
| 09/05/2007 | CN100335054C Quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for treatment of helicobacter pylori infections and associated gastroduodenal |
| 09/05/2007 | CN100335050C Compsn. of medication of silybum mariamum |
| 09/05/2007 | CN100335049C Anti-constipation composition |
| 09/05/2007 | CN100335040C Rapidly disintegrating tablet comprising acid-sensitive active ingredient |
| 09/05/2007 | CN100335039C Prepn process of micron fatigue eliminating Chinese medicine oral liquid |
| 09/05/2007 | CN100335037C Free-flowing, powdery composition containing alpha-liponic acid (-derivatives) |
| 09/05/2007 | CN100335015C Artificial kidney having function of metabolizing profein and method of constituting same |
| 09/05/2007 | CN100334964C Probiotic delivery system |
| 09/04/2007 | US7265228 N-(alpha-methylolbenzyl)1-(aminoethyl)- or 1-(aminocarbonyl)-2-aryl(especially phenyl or benzodioxanyl)-2-hydroxyethylamine intermediates for enantiomeric synthesis of amino ceramide-like compounds |
| 09/04/2007 | US7265227 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 09/04/2007 | US7265226 Interact with opoid receptors; decreasing metabolic rates of the phenolic piperidines by amidation, imidation, or forming a formamide, a hydroxyamidine or a thioamide; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction |
| 09/04/2007 | US7265221 Pyrrolo[2,3-d]pyrimidine compounds |
| 09/04/2007 | US7265203 Human cytokine receptor |
| 09/04/2007 | US7265146 Administering small molecule compounds, especially acids or esters, that inhibit the interaction between alpha 4 integrins and ligands MAdCAM and/or VCAM for treatment of chronic inflammatory diseases such as arthritis, asthma, multiple sclerosis, Chrohn's disease, ulcerative colitis, and hepatitis C |
| 09/04/2007 | US7265139 RXR activating molecules |
| 09/04/2007 | US7265132 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 09/04/2007 | US7265125 4-Heteroaminoquinazoline derivatives,.e.g., 2-methyl-4-piperidin-1-yl-7-pyridin-3-yl-quinazoline; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity. |
| 09/04/2007 | US7265119 For therapy of nicotine dependency |
| 09/04/2007 | US7265113 Anticancer agents; antiinflammatory agents, for therapy of rheumatoid arthritis |
| 09/04/2007 | US7265110 Psychological disorders; antidepressants; anxiolytic agents; analgesics; antiinflammatory agents; central nervous system disorders |
| 09/04/2007 | US7265089 KGF polypeptide compositions |
| 09/04/2007 | US7264807 Administering to human therapeutically effective amount of antibody which binds to tropomyosin isoform associated with ulcerative colitis |
| 09/04/2007 | US7264798 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus |
| 09/04/2007 | CA2409999C Optical polymer mixtures for gastric retentive tablets |
| 09/04/2007 | CA2320162C Composition for the treatment of halitosis |
| 09/04/2007 | CA2297911C Substituted 6-phenylphenanthridines |
| 09/04/2007 | CA2269132C Compositions to control oral microbial oxidation-reduction (eh) levels |
| 09/04/2007 | CA2232450C Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
| 09/04/2007 | CA2219311C 10,13,15-trioxatricyclo[9.2.1.1.9.6]-pentadecanone derivatives, method for their production and pharmaceutical compositions containing them |
| 09/04/2007 | CA2215329C Colorectal chemoprotective composition and method for preventing colorectal cancer |
| 09/04/2007 | CA2134479C Laser treatment |
| 08/30/2007 | WO2007098106A2 Respiratory tract delivery of interferon-tau |
| 08/30/2007 | WO2007097976A1 Process for preparing intermediates to 5-ht4 receptor agonist compounds |
| 08/30/2007 | WO2007097461A1 Antibody for treatment of hepatitis c |
| 08/30/2007 | WO2007097403A1 Remedy or preventive for digestive ulcer |
| 08/30/2007 | WO2007097276A1 Pyrrole derivative or salt thereof |
| 08/30/2007 | WO2007097197A1 Amide derivative or salt thereof |
| 08/30/2007 | WO2007096839A1 Process for promoting overall health of an animal |
| 08/30/2007 | WO2007096838A1 Animal food composition comprising nut shell |
| 08/30/2007 | WO2007096596A2 Use of il-8 for the treatment of crohn' s disease |
| 08/30/2007 | WO2007096352A1 5-amino-6-bromo-n-{ [1- (tetrahydr0-2h-pyran-4-ylmethyl) -4-piperidinyl] methyl}-3, 4 -dihydro-2h-chromene-8-carboxamide as 5-ht4 receptor agonist |
| 08/30/2007 | WO2007079214A3 Prokineticin 2 receptor antagonists |
| 08/30/2007 | WO2007079163A3 Prokineticin 1 receptor antagonists |
| 08/30/2007 | WO2007073303A3 Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors |
| 08/30/2007 | WO2007042932A3 A composition for the treatment of oral lesions |
| 08/30/2007 | WO2007042925A3 A composition for the treatment of diabetic periodontitis |
| 08/30/2007 | WO2006134497A3 Uses of recombinant super-compound interferons |
| 08/30/2007 | WO2006122162A3 Use of peptides derived from the growth factor amp-18 for the treatment of mucositis |
| 08/30/2007 | WO2006063837A8 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
| 08/30/2007 | US20070203337 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/30/2007 | US20070203223 Via amino ceramide-like compounds; lowering glycosphingolipid concentrations; Fabry's disease, Gaucher's disease |
| 08/30/2007 | US20070203152 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 08/30/2007 | US20070203151 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 08/30/2007 | US20070203150 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 08/30/2007 | US20070203141 Method for administering birb 796 bs |
| 08/30/2007 | US20070203139 Aryl Glycinamide Derivatives And Their Use As Nk1 Antagonists And Serotonin Reuptake Inhibitors |
| 08/30/2007 | US20070203138 Novel Compounds and Compositions as Cathepsin S Inhibitors |
| 08/30/2007 | US20070203063 Pharmaceutical compositions including variants of vascular endothelial cell growth factor having altererd pharmacological properties |
| 08/30/2007 | US20070202501 Proteins Expressed In Ink Cells |
| 08/30/2007 | US20070202204 Plant extract mixtures and their uses |
| 08/30/2007 | US20070202198 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors biofilters and bioreactors |
| 08/30/2007 | US20070202196 Plant extract mixtures and their uses |
| 08/30/2007 | US20070202181 Low hygroscopic aripipazole drug substance and processes for the preparation thereof |
| 08/30/2007 | US20070202171 Method Of Producing A Pharmaceutical Composition |
| 08/30/2007 | US20070202160 Solid-state form of celecoxib having enhanced bioavailability |
| 08/30/2007 | US20070202100 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
| 08/30/2007 | DE60122300T2 Hepatitis b kernprotein fusionsproteine Hepatitis B core protein fusion proteins |
| 08/30/2007 | CA2643925A1 Animal food composition comprising nut shell |
| 08/30/2007 | CA2643746A1 Process for promoting overall health of an animal |
| 08/30/2007 | CA2643272A1 Gent for treating or preventing digestive ulcer |
| 08/30/2007 | CA2642619A1 Pyrrole derivative or salt thereof |
| 08/30/2007 | CA2642610A1 Amide derivative or salt thereof |
| 08/30/2007 | CA2637214A1 Process for preparing 8-azabicylo[3.2.1]octan-3-one intermediates to 5-ht4 receptor agonist compounds |
| 08/29/2007 | EP1826197A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 08/29/2007 | EP1825857A1 Agent for ameliorating the maximum passage time through digestive tract, agent for ameliorating passage time through digestive tract and preventive for colon cancer |
| 08/29/2007 | EP1825856A1 Oral composition containing difructose anhydride |
| 08/29/2007 | EP1824850A2 SUBSTITUTED IMIDAZO[4,5-b]PYRIDINES AS INHIBITORS OF GASTRIC ACID SECRETION |
| 08/29/2007 | EP1824829A1 3-substituted pyridine derivatives as h3 antagonists |
| 08/29/2007 | EP1824563A1 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy |
| 08/29/2007 | EP1824475A1 Methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol |
| 08/29/2007 | EP1694656B1 Benzoxazine derivatives and uses thereof |
| 08/29/2007 | EP1441700B1 Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease |
| 08/29/2007 | EP1423126B1 Treatment of hyperproliferative conditions of body surfaces |